Understanding Chronically Elevated Mean Platelet Volume (MPV)
A chronically elevated Mean Platelet Volume (MPV) indicates the presence of larger, more reactive platelets that may be associated with increased thrombotic risk and can serve as a marker for various underlying conditions including myeloproliferative disorders, inflammatory states, and cardiovascular disease. 1
What is MPV?
- MPV is a measurement of the average size of platelets in the blood and serves as an indicator of platelet function and activation 2
- Normal MPV range is typically 7.5-11.5 fL (femtoliters), though reference ranges may vary between laboratories 1
- Larger platelets (elevated MPV) are metabolically and enzymatically more active, containing more granules and adhesion receptors, making them more thrombogenic 2
Clinical Significance of Elevated MPV
Cardiovascular Implications
- Elevated MPV is an independent risk factor for cardiovascular events, including myocardial infarction and stroke 2
- High MPV values correlate with shortened bleeding time and increased thromboxane B2 plasma levels, indicating enhanced platelet reactivity 2
- In patients with non-ST elevation acute coronary syndrome, elevated MPV is independently associated with increased risk of adverse cardiovascular outcomes 3
- The combination of elevated MPV and aspirin resistance significantly worsens prognosis in patients with acute coronary syndromes 4
Hematologic Disorders
- High MPV with low platelet count typically indicates hyperdestructive thrombocytopenia (such as immune thrombocytopenia) 1
- High MPV with normal platelet count may be seen in heterozygous thalassemia or iron deficiency 1
- High MPV with high platelet count can indicate myeloproliferative disorders, post-splenectomy state, inflammation, or iron deficiency 1
Other Associated Conditions
- Elevated MPV is associated with various metabolic conditions including obesity, diabetes mellitus, and metabolic syndrome 2
- Inflammatory states can affect platelet size through the influence of cytokines and growth factors on megakaryocytopoiesis 2
- In polycythemia vera, platelet abnormalities including altered size may be present alongside other hematologic changes 5
Pathophysiology
- Platelet size is primarily determined during megakaryocytopoiesis in the bone marrow and generally remains stable in circulation 2
- Growth factors and inflammatory cytokines can stimulate the production of larger, more reactive platelets 2
- In 22q11.2 deletion syndrome, mild to moderate thrombocytopenia with increased platelet volume is common, possibly related to heterozygosity of the GPIBB gene 5
Diagnostic Approach
- Complete blood count with review of platelet parameters should be the initial step in evaluation 6
- Assessment should include platelet count alongside MPV to properly categorize the condition 1
- Serial measurements are more valuable than isolated readings to establish chronicity 6
- Additional testing should be guided by clinical presentation and may include:
Clinical Management
- Treatment should be directed at the underlying cause rather than the elevated MPV itself 6
- For patients with elevated cardiovascular risk, consider more aggressive cardiovascular risk factor modification 3, 2
- In patients with elevated MPV and cardiovascular disease, evaluate for aspirin resistance, as this combination significantly worsens prognosis 4
- Monitor for bleeding risk in patients with very high MPV and thrombocytopenia, as acquired von Willebrand disease may occur in certain conditions like polycythemia vera 5
Important Considerations and Pitfalls
- MPV measurement can be affected by methodological issues including time from collection to analysis and temperature 7
- EDTA anticoagulant causes platelets to swell over time, potentially falsely elevating MPV if analysis is delayed 7
- An isolated elevated MPV without clinical context has limited diagnostic value; interpretation should always consider the complete clinical picture 1
- Don't overlook the possibility of coexisting conditions, such as iron deficiency with myeloproliferative disorders 6